Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL c
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Suresh Veeramani George J Weiner Clive S Zent Brian K Link Timothy G. Call |
| Publication date | April 26, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |